project id: TCGA-LUAD; case submitter id: TCGA-64-1680; selected normal wgs: true; selected normal wxs: true; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 9.2; spectrophotometer method: UV Spec; age at index: 63; days to birth: -23267; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1944; age at diagnosis: 23267; ajcc pathologic m: M1; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1126.0; icd 10 code: C34.8; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of lung; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of lung; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 2.73972602739726; pack years smoked: 50.0; years smoked: 20.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.4; longest dimension: 1.2; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-64-1680-01A-02; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor nuclei: 90.0;